ASTELLAS PHARMA UNSP.ADR Defensive Interval Ratio
ASTELLAS PHARMA UNSP.ADR defensive interval ratio. ASTELLAS PHARMA UNSP.ADR (YPHA) has a Defensive Interval Ratio of 228 days as of March 2025. Defensive assets of €662.47 Billion (cash €-, short-term investments €29.94 Billion, receivables €632.52 Billion) cover 228 days of daily cash needs of €2.91 Billion/day. See YPHA working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of ASTELLAS PHARMA UNSP.ADR (2022–2025)
Defensive interval ratio of ASTELLAS PHARMA UNSP.ADR from 2022 to 2025. This chart shows how ASTELLAS PHARMA UNSP.ADR's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2025, the ratio stands at 228 days, meaning defensive assets of €662.47 Billion can fund 228 days of operations without new revenue. Check YPHA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
ASTELLAS PHARMA UNSP.ADR Defensive Interval Ratio by Year (2022–2025)
ASTELLAS PHARMA UNSP.ADR defensive interval ratio by year from 2022 to 2025. The table below presents the year-by-year Defensive Interval Ratio for ASTELLAS PHARMA UNSP.ADR from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see total assets of ASTELLAS PHARMA UNSP.ADR.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 228 days | €662.47 Billion | €2.91 Billion/day | €- | €29.94 Billion | ▲ +68 days |
| 2024 | 160 days | €563.77 Billion | €3.52 Billion/day | €- | €28.78 Billion | ▼ -65 days |
| 2023 | 225 days | €447.75 Billion | €1.99 Billion/day | €- | €19.78 Billion | ▲ +11 days |
| 2022 | 214 days | €403.76 Billion | €1.88 Billion/day | €- | €21.30 Billion | — |